FMR1 Antikörper (AA 116-130)
-
- Target Alle FMR1 Antikörper anzeigen
- FMR1 (Fragile X Mental Retardation 1 (FMR1))
-
Bindungsspezifität
- AA 116-130
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser FMR1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Verwendungszweck
- FMR1 (aa116-130)
- Sequenz
- NPNKPATKDT FHKIK
- Kreuzreaktivität
- Human, Ratte
- Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Güteklasse
- Verified
- Immunogen
- Peptide with sequence C-NPNKPATKDTFHKIK, from the internal region of the protein sequence according to NP_002015.1.
- Isotyp
- IgG
- Top Product
- Discover our top product FMR1 Primärantikörper
-
anti-Fragile X Mental Retardation 1 (FMR1) antibody
FMR1 Reaktivität: Human WB, IHC, IF, IHC (p), FACS Wirt: Maus Monoclonal 3B4 unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) (AA 36-279) antibodyFMR1 Reaktivität: Human, Maus, Ratte, Hund, Affe WB, IHC, IF, IHC (p), FACS Wirt: Maus Monoclonal 1C6 unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) (AA 26-279) antibodyFMR1 Reaktivität: Human, Maus, Ratte, Hund, Affe WB, IHC, IHC (p) Wirt: Maus Monoclonal 2C3 unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) (AA 121-220) antibodyFMR1 Reaktivität: Human WB, ELISA, RNAi Wirt: Maus Monoclonal 2D4 unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) (AA 20-48), (N-Term) antibodyFMR1 Reaktivität: Human, Maus WB, IHC (p), FACS Wirt: Kaninchen Polyclonal RB20964 unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) (AA 1-290) antibodyFMR1 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) (AA 500-600) antibodyFMR1 Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) antibodyFMR1 Reaktivität: Human IHC, ELISA, ICC Wirt: Maus Monoclonal 4G9 unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) (AA 121-220) antibodyFMR1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3E11 unconjugated
anti-Fragile X Mental Retardation 1 (FMR1) (pSer500) antibodyFMR1 Reaktivität: Human, Maus, Ratte, Zebrafisch (Danio rerio) WB, ELISA, IHC (p), IF (cc), IF (p), ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Immunohistochemistry: Paraffin embedded Human Brain (Cortex) and Placenta. Recommended concentration: 2.5 μg/mL.
Western Blot: Approx 70 kDa band observed in lysates of cell lines HeLa, Jurkat and Kelly (calculated MW of 71.2 kDa according to NP_002015.1). Recommended concentration: 0.3-1 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:32000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Target
- FMR1 (Fragile X Mental Retardation 1 (FMR1))
- Andere Bezeichnung
- FMR1 (FMR1 Produkte)
- Hintergrund
- FMR1, fragile X mental retardation 1, FMRP, FRAXA, MGC87458
- Gen-ID
- 2332, 24948
- NCBI Accession
- NP_002015
- Pathways
- Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
-
